pramipexole has been researched along with Depressive Disorder, Major in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attenburrow, MJ; Au-Yeung, SK; Bogacz, R; Browning, M; Chan, F; Cipriani, A; Cleare, A; Cowen, P; Edwards, C; Evans, J; Geddes, J; Griffiths, J; Harmer, CJ; Harrison, PJ; Kessler, D; Lewis, G; Rendell, J; Roberts, S; Shanyinde, M; Simon, J; Singh, I; Watson, S; Yu, LM | 1 |
| Abi-Dargham, A; Ang, YS; Iosifescu, DV; McGrath, PJ; Pizzagalli, DA; Reinen, JM; Schneier, FR; Slifstein, M; Whitton, AE | 1 |
| DiMario, K; Fedoroff, JP; Ly, T; Mihowich, T; Murphy, L | 1 |
| Betro', S; de Filippis, R; Iommi, M; Tundo, A | 1 |
| De Crescenzo, F; de Filippis, R; Tundo, A | 1 |
| Franco-Chaves, JA; Luckenbaugh, DA; Mallinger, AG; Martinez, PE; Mateus, CF; Zarate, CA | 1 |
| Arnulf, I; Brion, A; Launois, C; Leu-Semenescu, S | 1 |
| Cusin, C; Fava, M; Iosifescu, DV; Iovieno, N; Nierenberg, AA; Perlis, RH; Rush, AJ | 1 |
| Hara, C; Rocha, FL | 1 |
| Diaz, SH; Dunklee, L; Escalona, R; Fawcett, J; Romo, P; Rush, AJ; Vukelich, J; Yarns, BC | 1 |
| Letvinenko, IV; Mogil'naia, VI; Odinak, MM | 1 |
| Nibuya, M; Nomura, S; Takahashi, T | 1 |
| Boku, S; Inoue, T; Kitaichi, Y; Koyama, T; Masui, T; Nakagawa, S; Nakato, Y; Suzuki, K; Tanaka, T; Usui, R | 1 |
| Abelli, M; Bassi, A; Battistini, G; Cassano, GB; Cassano, P; Dell'Osso, L; Gemignani, A; Houck, PR; Lattanzi, L; Pini, S; Rucci, P | 1 |
| Burdick, KE; Endick, CJ; Goldberg, JF | 1 |
| Battistini, G; Cassano, GB; Cassano, P; Gemignani, A; Lattanzi, L; Navari, S; Soldani, F | 1 |
| Frank, B; Gupta, S; Vincent, JL | 1 |
| Antonini, A; Barone, P; Bracco, F; Marconi, R; Morgante, L; Musch, B; Scarzella, L; Zappia, M | 1 |
| Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB | 1 |
| Corrigan, MH; Denahan, AQ; Evans, DL; Ragual, RJ; Wright, CE | 1 |
1 review(s) available for pramipexole and Depressive Disorder, Major
| Article | Year |
|---|---|
Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Case-Control Studies; Depressive Disorder, Major; Dopamine Agonists; Female; Humans; Male; Middle Aged; Observational Studies as Topic; Placebos; Pramipexole; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2019 |
10 trial(s) available for pramipexole and Depressive Disorder, Major
| Article | Year |
|---|---|
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
Topics: Adult; Antidepressive Agents; Benzothiazoles; Citalopram; Depressive Disorder, Major; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Pramipexole; Selective Serotonin Reuptake Inhibitors | 2013 |
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Benzothiazoles; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome | 2013 |
[Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole].
Topics: Aged; Amantadine; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Movement Disorders; Pain; Pain Measurement; Parkinson Disease; Pramipexole; Severity of Illness Index | 2008 |
Pramipexole for stage 2 treatment-resistant major depression: an open study.
Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pilot Projects; Pramipexole; Prospective Studies; Treatment Outcome | 2010 |
Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Benzothiazoles; Combined Modality Therapy; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2002 |
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
Topics: Adult; Ambulatory Care; Anticonvulsants; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Pilot Projects; Pramipexole; Thiazoles | 2004 |
Pramipexole in treatment-resistant depression: an extended follow-up.
Topics: Acute Disease; Adult; Aged; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2004 |
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 2006 |
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Assessment; Pramipexole; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2000 |
9 other study(ies) available for pramipexole and Depressive Disorder, Major
| Article | Year |
|---|---|
Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression.
Topics: Adult; Depression; Depressive Disorder, Major; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Learning; Male; Middle Aged; Pramipexole; Reward | 2020 |
Treatment of Pramipexole-Induced Problematic Sexual Behaviors.
Topics: Adult; Compulsive Behavior; Depressive Disorder, Major; Dopamine Agonists; Humans; Male; Pramipexole; Restless Legs Syndrome | 2021 |
Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Brief Psychiatric Rating Scale; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Off-Label Use; Pramipexole; Retrospective Studies; Treatment Outcome | 2022 |
Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
Topics: Aged, 80 and over; Benzothiazoles; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome | 2013 |
Compulsive Masturbation With Pramipexole for Antidepressant Augmentation in Major Depression: A Case Report.
Topics: Antidepressive Agents; Benzothiazoles; Compulsive Behavior; Depressive Disorder, Major; Dopamine Agonists; Female; Humans; Masturbation; Middle Aged; Pramipexole | 2015 |
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Bupropion; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline; Pramipexole; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Delusion of Cotard's syndrome successfully treated with a dopamine agonist.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Benzothiazoles; Delusions; Depressive Disorder, Major; Dopamine Agonists; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Pramipexole; Recurrence; Syndrome; Treatment Outcome | 2010 |
Pramipexole: augmentation in the treatment of depressive symptoms.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Pramipexole; Somatoform Disorders; Thiazoles | 2006 |
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles | 2000 |